Chemoselective Amination of 5‐Bromo‐2‐chloro‐3‐fluoropyridine.
Bryan W. Stroup, Michael H. Serrano‐Wu(Broad Institute), Cornelia J. Forster(Novartis (United States)), Paul V. Szklennik
Cited by 0
Related Papers
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
|Nature|2010|940
Identification of Hepatitis C Virus NS5A Inhibitors
|Journal of Virology|2009|196
Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes
|ACS Medicinal Chemistry Letters|2011|86
Sordaricin antifungal agents
|Bioorganic & Medicinal Chemistry Letters|2003|62